(Replying to PARENT post)
(I'm using 2015 figures because they were the latest available the last time I challenged this bullshit)
Nope, drugs sales in the EU alone are enough to cover pharmaceutical R&D costs worldwide. What they aren't enough to cover is Marketing costs, but that's OK since most EU countries don't allow direct marketing of drugs.
That's what the US covers. Not quite so noble sounding that you're covering the cost of advertising though, is it?
Pharmaceutical R&D spending in 2015: USA $47B, Europe: $33B.
Total drug sales Europe 2015: $190B
👤phaemon🕑5y🔼0🗨️0
(Replying to PARENT post)
Do we have good data on what happens if you change the IP laws around drugs to reduce the moat that the developers get?
A common claim by big-pharma defenders is that if you take away the gouging aspect, drug development will stop. Is there some way we can test this experimentally on a subset of the drug market?
👤Taek🕑5y🔼0🗨️0
(Replying to PARENT post)
I don't know how prevalent this is but i remember watching AOC questioning gilead execs on "stealing" HIV patent for the drug and selling drug back to public for exorbitant prices.
https://www.nytimes.com/2019/11/07/business/gilead-truvada-h...
is corruption only explanation of how this happened?
👤dominotw🕑5y🔼0🗨️0
(Replying to PARENT post)
https://www.wsj.com/amp/articles/how-other-countries-freeloa...